The Israel Ministry of Defense (MoD) has finalised a contract with Israel Aerospace Industries (IAI) to increase the production of Arrow-3 interceptors.
The trial will evaluate the immunogenicity and safety of the CIC and stand-alone seasonal influenza vaccine candidates compared to Novavax's updated 2024-2025 COVID-19 vaccine (NVX-CoV2705 ...